Chie Kohchi

Acquired a Ph.D. of Engineering at Graduate School of Engineering, Hiroshima University. After that, engaged in research at Pfizer Pharmaceutical Co., Ltd., Japan Society for the Promotion of Science (Cancer Special Researcher), Bioengineering Research Center, Teikyo University (Assistant), Isotope Center, Hiroshima University (Assistant), and School of Medicine, Kagawa University (Visiting Professor). Since 2007, the representative director of Macrophi Inc. Research contents are physiological function related to innate immune activation of orally percutaneously ingested lipopolysaccharide (LPS). Macrophi Inc. manufactures and sells LPS as a functional material for food or cosmetics.